Limoneira Company (NASDAQ:LMNR) Q3 2024 Earnings Conference Call September 9, 2024 4:30 PM ET
Company Participants
John Mills - IR, ICR
Harold Edwards - President & CEO
Mark Palamountain - CFO
Conference Call Participants
Ben Klieve - Lake Street Capital Markets
Raj Sharma - B. Riley Securities
Operator
Greetings, and welcome to Limoneira's Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation.
It’s now my pleasure to introduce your host, John Mills with ICR. Thank you, sir. You may begin.
John Mills
Great. Thank you. Good afternoon, everyone, and thank you for joining us for Limoneira's third quarter fiscal year 2024 conference call. On the call today are Harold Edwards, President and Chief Executive Officer, and Mark Palamountain, Evecutive Vice President, and Chief Financial Officer. By now, everyone should have access to the third quarter fiscal year 2024 earnings release, which went out today at approximately 4:00 p.m. Eastern time. If you've not had a chance to review the release, it's available on the Investor Relations portion of the company's website at limoneira.com. This call is being webcast, and a replay will be available on Limoneira's website as well.
Before we begin, we would like to remind everyone that prepared remarks contain forward-looking statements, and management may make additional forward-looking statements in response to your questions. Such statements involve a number of known and unknown risks and uncertainties, many of which are outside the company's control and could cause its future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements.
Important factors that could cause or contribute to such differences include risk details in the company's Form 10-Qs and 10-Ks filed with
- Read more current LMNR analysis and news
- View all earnings call transcripts